CDT Equity Inc.
CDTTW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $81.8K in total; no superinvestor holds it.
Other share classesCDT
Q4 2024 vs. Q3 2024
How the institutions holding CDT Equity Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 26 | 20 | −6 |
| Shares | 7.12M | 6.23M | −888.4K (−12.5%) |
| Value | $110.7K | $44.2K | −$66.6K (−60.1%) |
New holders (1)
Institutions that held CDT Equity Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Decagon Asset Management LLP | 400,000 | $2.36K | 0.00% |
Sold out (7)
Institutions that held CDT Equity Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Cowen and Company, LLC | 200,745 | $2.37K |
| Whitebox Advisors LLC | 200,000 | $2.36K |
| Altium Capital Management LP | 100,000 | $1.59K |
| Mizuho Securities USA LLC | 100,000 | $1.00K |
| Hudson Bay Capital Management LP | 59,101 | $697 |
| Susquehanna International Group, LLP | 24,495 | $289 |
| UBS Group AG | 516 | $6 |